GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Becton, Dickinson and Co (XSWX:BDX) » Definitions » Days Sales Outstanding

Becton, Dickinson and Co (XSWX:BDX) Days Sales Outstanding : 43.10 (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Becton, Dickinson and Co Days Sales Outstanding?

Becton, Dickinson and Co's average Accounts Receivable for the three months ended in Mar. 2024 was CHF2,117 Mil. Becton, Dickinson and Co's Revenue for the three months ended in Mar. 2024 was CHF4,483 Mil. Hence, Becton, Dickinson and Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 43.10.

The historical rank and industry rank for Becton, Dickinson and Co's Days Sales Outstanding or its related term are showing as below:

XSWX:BDX' s Days Sales Outstanding Range Over the Past 10 Years
Min: 43.92   Med: 48.27   Max: 53.85
Current: 45.12

During the past 13 years, Becton, Dickinson and Co's highest Days Sales Outstanding was 53.85. The lowest was 43.92. And the median was 48.27.

XSWX:BDX's Days Sales Outstanding is ranked better than
77.23% of 808 companies
in the Medical Devices & Instruments industry
Industry Median: 64.725 vs XSWX:BDX: 45.12

Becton, Dickinson and Co's Days Sales Outstanding declined from Mar. 2023 (44.57) to Mar. 2024 (43.10).


Becton, Dickinson and Co Days Sales Outstanding Historical Data

The historical data trend for Becton, Dickinson and Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Becton, Dickinson and Co Days Sales Outstanding Chart

Becton, Dickinson and Co Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 48.68 56.05 45.10 42.74 46.20

Becton, Dickinson and Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 44.57 45.78 44.40 47.53 43.10

Competitive Comparison of Becton, Dickinson and Co's Days Sales Outstanding

For the Medical Instruments & Supplies subindustry, Becton, Dickinson and Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Becton, Dickinson and Co's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Becton, Dickinson and Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Becton, Dickinson and Co's Days Sales Outstanding falls into.



Becton, Dickinson and Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Becton, Dickinson and Co's Days Sales Outstanding for the fiscal year that ended in Sep. 2023 is calculated as

Days Sales Outstanding (A: Sep. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Sep. 2022 ) + Accounts Receivable (A: Sep. 2023 )) / count ) / Revenue (A: Sep. 2023 )*Days in Period
=( (2132.5 + 2279.586) / 2 ) / 17427.051*365
=2206.043 / 17427.051*365
=46.20

Becton, Dickinson and Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding (Q: Mar. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2023 ) + Accounts Receivable (A: Mar. 2024 )) / count ) / Revenue (A: Mar. 2024 )*Days in Period
=( (1960.502 + 2273.927) / 2 ) / 4482.987*365 / 4
=2117.2145 / 4482.987*365 / 4
=43.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Becton, Dickinson and Co  (XSWX:BDX) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Becton, Dickinson and Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Becton, Dickinson and Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Becton, Dickinson and Co (XSWX:BDX) Business Description

Address
1 Becton Drive, Franklin Lakes, NJ, USA, 07417-1880
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures pre-filled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (26% of estimated 2023 revenue) and BD Interventional (25%) account for the remainder. International revenue accounts for 43% of the company's business.

Becton, Dickinson and Co (XSWX:BDX) Headlines